New Codes for 2019

A4563

A

Rectal control system for vaginal insertion, for long term use, includes pump

A5514

A

For diabetics only, multiple density insert, made by direct carving with cam

A6460

A

Synthetic resorbable wound dressing, sterile, pad size 16 sq. in. or less,

A6461

A

Synthetic resorbable wound dressing, sterile, pad size more than 16 sq. in. but

A9513

A

Lutetium lu 177, dotatate, therapeutic, 1 millicurie

A9589

A

Instillation, hexaminolevulinate hydrochloride, 100 mg

B4105

A

In-line cartridge containing digestive enzyme(s) for enteral feeding, each

C1823

A

Generator, neurostimulator (implantable), non-rechargeable, with transvenous

C8937

A

Computer-aided detection, including computer algorithm analysis of breast mri

C9034

A

Injection, dexamethasone 9%, intraocular, 1 mcg

C9035

A

Injection, aripiprazole lauroxil (aristada initio), 1 mg

C9036

A

Injection, patisiran, 0.1 mg

C9037

A

Injection, risperidone (perseris), 0.5 mg

C9038

A

Injection, mogamulizumab-kpkc, 1 mg

C9039

A

Injection, plazomicin, 5 mg

C9407

A

Iodine i-131 iobenguane, diagnostic, 1 millicurie

C9408

A

Iodine i-131 iobenguane, therapeutic, 1 millicurie

C9462

A

Injection, delafloxacin, 1 mg

C9749

A

Repair of nasal vestibular lateral wall stenosis with implant(s)

C9751

A

Bronchoscopy, rigid or flexible, transbronchial ablation of lesion(s) by

C9752

A

Destruction of intraosseous basivertebral nerve, first two vertebral bodies,

C9753

A

Destruction of intraosseous basivertebral nerve, each additional vertebral

C9754

A

Creation of arteriovenous fistula, percutaneous; direct, any site, including

C9755

A

Creation of arteriovenous fistula, percutaneous using magnetic-guided arterial

D0412

A

Blood glucose level test - in-office using a glucose meter

D1516

A

Space maintainer - fixed - bilateral, maxillary

D1517

A

Space maintainer - fixed - bilateral, mandibular

D1526

A

Space maintainer - removable - bilateral, maxillary

D1527

A

Space maintainer - removable - bilateral, mandibular

D5282

A

Removable unilateral partial denture - one piece cast metal (including clasps

D5283

A

Removable unilateral partial denture - one piece cast metal (including clasps

D5876

A

Add metal substructure to acrylic full denture (per arch)

D9130

A

Temporomandibular joint dysfunction - non-invasive physical therapies

D9613

A

Infiltration of sustained release therapeutic drug - single or multiple sites

D9944

A

Occlusal guard - hard appliance, full arch

D9945

A

Occlusal guard - soft appliance, full arch

D9946

A

Occlusal guard - hard appliance, partial arch

D9961

A

Duplicate/copy patient's records

D9990

A

Certified translation or sign-language services - per visit

E0447

A

Portable oxygen contents, liquid, 1 month's supply = 1 unit, prescribed amount

E0467

A

Home ventilator, multi-function respiratory device, also performs any or all of

G0068

A

Professional services for the administration of anti-infective, pain

G0069

A

Professional services for the administration of subcutaneous immunotherapy for

G0070

A

Professional services for the administration of chemotherapy for each infusion

G0071

A

Payment for communication technology-based services for 5 minutes or more of a

G0076

A

Brief (20 minutes) care management home visit for a new patient. for use only

G0077

A

Limited (30 minutes) care management home visit for a new patient. for use only

G0078

A

Moderate (45 minutes) care management home visit for a new patient. for use

G0079

A

Comprehensive (60 minutes) care management home visit for a new patient. for

G0080

A

Extensive (75 minutes) care management home visit for a new patient. for use

G0081

A

Brief (20 minutes) care management home visit for an existing patient. for use

G0082

A

Limited (30 minutes) care management home visit for an existing patient. for

G0083

A

Moderate (45 minutes) care management home visit for an existing patient. for

G0084

A

Comprehensive (60 minutes) care management home visit for an existing patient.

G0085

A

Extensive (75 minutes) care management home visit for an existing patient. for

G0086

A

Limited (30 minutes) care management home care plan oversight. for use only in

G0087

A

Comprehensive (60 minutes) care management home care plan oversight. for use

G2000

A

Blinded administration of convulsive therapy procedure, either

G2010

A

Remote evaluation of recorded video and/or images submitted by an established

G2011

A

Alcohol and/or substance (other than tobacco) abuse structured assessment

G2012

A

Brief communication technology-based service, e.g. virtual check-in, by a

G9873

A

First medicare diabetes prevention program (mdpp) core session was attended by

G9874

A

Four total medicare diabetes prevention program (mdpp) core sessions were

G9875

A

Nine total medicare diabetes prevention program (mdpp) core sessions were

G9876

A

Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms)

G9877

A

Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms)

G9878

A

Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms)

G9879

A

Two medicare diabetes prevention program (mdpp) core maintenance sessions (ms)

G9880

A

The mdpp beneficiary achieved at least 5% weight loss (wl) from his/her

G9881

A

The mdpp beneficiary achieved at least 9% weight loss (wl) from his/her

G9882

A

Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions

G9883

A

Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions

G9884

A

Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions

G9885

A

Two medicare diabetes prevention program (mdpp) ongoing maintenance sessions

G9890

A

Bridge payment: a one-time payment for the first medicare diabetes prevention

G9891

A

Mdpp session reported as a line-item on a claim for a payable mdpp expanded

G9978

A

Remote in-home visit for the evaluation and management of a new patient for use

G9979

A

Remote in-home visit for the evaluation and management of a new patient for use

G9980

A

Remote in-home visit for the evaluation and management of a new patient for use

G9981

A

Remote in-home visit for the evaluation and management of a new patient for use

G9982

A

Remote in-home visit for the evaluation and management of a new patient for use

G9983

A

Remote in-home visit for the evaluation and management of an established

G9984

A

Remote in-home visit for the evaluation and management of an established

G9985

A

Remote in-home visit for the evaluation and management of an established

G9986

A

Remote in-home visit for the evaluation and management of an established

G9987

A

Bundled payments for care improvement advanced (bpci advanced) model home visit

J0185

A

Injection, aprepitant, 1 mg

J0517

A

Injection, benralizumab, 1 mg

J0567

A

Injection, cerliponase alfa, 1 mg

J0584

A

Injection, burosumab-twza 1 mg

J0599

A

Injection, c-1 esterase inhibitor (human), (haegarda), 10 units

J0841

A

Injection, crotalidae immune f(ab')2 (equine), 120 mg

J1301

A

Injection, edaravone, 1 mg

J1454

A

Injection, fosnetupitant 235 mg and palonosetron 0.25 mg

J1628

A

Injection, guselkumab, 1 mg

J1746

A

Injection, ibalizumab-uiyk, 10 mg

J2062

A

Loxapine for inhalation, 1 mg

J2797

A

Injection, rolapitant, 0.5 mg

J3245

A

Injection, tildrakizumab, 1 mg

J3304

A

Injection, triamcinolone acetonide, preservative-free, extended-release,

J3316

A

Injection, triptorelin, extended-release, 3.75 mg

J3397

A

Injection, vestronidase alfa-vjbk, 1 mg

J3398

A

Injection, voretigene neparvovec-rzyl, 1 billion vector genomes

J3591

A

Unclassified drug or biological used for esrd on dialysis

J7170

A

Injection, emicizumab-kxwh, 0.5 mg

J7177

A

Injection, human fibrinogen concentrate (fibryga), 1 mg

J7203

A

Injection factor ix, (antihemophilic factor, recombinant), glycopegylated,

J7318

A

Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg

J7329

A

Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg

J9044

A

Injection, bortezomib, not otherwise specified, 0.1 mg

J9057

A

Injection, copanlisib, 1 mg

J9153

A

Injection, liposomal, 1 mg daunorubicin and 2.27 mg cytarabine

J9173

A

Injection, durvalumab, 10 mg

J9229

A

Injection, inotuzumab ozogamicin, 0.1 mg

J9311

A

Injection, rituximab 10 mg and hyaluronidase

J9312

A

Injection, rituximab, 10 mg

L8608

A

Miscellaneous external component, supply or accessory for use with the argus ii

L8698

A

Miscellaneous component, supply or accessory for use with total artificial

L8701

A

Powered upper extremity range of motion assist device, elbow, wrist, hand with

L8702

A

Powered upper extremity range of motion assist device, elbow, wrist, hand,

M1000

A

Pain screened as moderate to severe

M1001

A

Plan of care to address moderate to severe pain documented on or before the

M1002

A

Plan of care for moderate to severe pain not documented on or before the date

M1003

A

Tb screening performed and results interpreted within twelve months prior to

M1004

A

Documentation of medical reason for not screening for tb or interpreting

M1005

A

Tb screening not performed or results not interpreted, reason not given

M1006

A

Disease activity not assessed, reason not given

M1007

A

>=50% of total number of a patient's outpatient ra encounters assessed

M1008

A

<50% of total number of a patient's outpatient ra encounters assessed

M1009

A

Patient treatment and final evaluation complete

M1010

A

Patient treatment and final evaluation complete

M1011

A

Patient treatment and final evaluation complete

M1012

A

Patient treatment and final evaluation complete

M1013

A

Patient treatment and final evaluation complete

M1014

A

Patient treatment and final evaluation complete

M1015

A

Patient treatment and final evaluation complete

M1016

A

Female patients unable to bear children

M1017

A

Patient admitted to palliative care services

M1018

A

Patients with an active diagnosis or history of cancer (except basal cell and

M1019

A

Adolescent patients 12 to 17 years of age with major depression or dysthymia

M1020

A

Adolescent patients 12 to 17 years of age with major depression or dysthymia

M1021

A

Patient had only urgent care visits during the performance period

M1022

A

Patients who were in hospice at any time during the performance period

M1023

A

Adolescent patients 12 to 17 years of age with major depression or dysthymia

M1024

A

Adolescent patients 12 to 17 years of age with major depression or dysthymia

M1025

A

Patients who were in hospice at any time during the performance period

M1026

A

Patients who were in hospice at any time during the performance period

M1027

A

Imaging of the head (ct or mri) was obtained

M1028

A

Documentation of patients with primary headache diagnosis and imaging other

M1029

A

Imaging of the head (ct or mri) was not obtained, reason not given

M1030

A

Patients with clinical indications for imaging of the head

M1031

A

Patients with no clinical indications for imaging of the head

M1032

A

Adults currently taking pharmacotherapy for oud

M1033

A

Pharmacotherapy for oud initiated after june 30th of performance period

M1034

A

Adults who have at least 180 days of continuous pharmacotherapy with a

M1035

A

Adults who are deliberately phased out of medication assisted treatment (mat)

M1036

A

Adults who have not had at least 180 days of continuous pharmacotherapy with a

M1037

A

Patients with a diagnosis of lumbar spine region cancer at the time of the

M1038

A

Patients with a diagnosis of lumbar spine region fracture at the time of the

M1039

A

Patients with a diagnosis of lumbar spine region infection at the time of the

M1040

A

Patients with a diagnosis of lumbar idiopathic or congenital scoliosis

M1041

A

Patient had cancer, fracture or infection related to the lumbar spine or

M1042

A

Functional status measurement with score was obtained utilizing the oswestry

M1043

A

Functional status measurement with score was not obtained utilizing the

M1044

A

Functional status was measured by the oswestry disability index (odi version

M1045

A

Functional status measurement with score was obtained utilizing the oxford knee

M1046

A

Functional status measurement with score was not obtained utilizing the oxford

M1047

A

Functional status was measured by the oxford knee score (oks) patient reported

M1048

A

Functional status measurement with score was obtained utilizing the oswestry

M1049

A

Functional status measurement with score was not obtained utilizing the

M1050

A

Functional status was measured by the oswestry disability index (odi version

M1051

A

Patient had cancer, fracture or infection related to the lumbar spine or

M1052

A

Leg pain was not measured by the visual analog scale (vas) within three months

M1053

A

Leg pain was measured by the visual analog scale (vas) within three months

M1054

A

Patient had only urgent care visits during the performance period

M1055

A

Aspirin or another antiplatelet therapy used

M1056

A

Prescribed anticoagulant medication during the performance period, history of

M1057

A

Aspirin or another antiplatelet therapy not used, reason not given

M1058

A

Patient was a permanent nursing home resident at any time during the

M1059

A

Patient was in hospice or receiving palliative care at any time during the

M1060

A

Patient died prior to the end of the performance period

M1061

A

Patient pregnancy

M1062

A

Patient immunocompromised

M1063

A

Patients receiving high doses of immunosuppressive therapy

M1064

A

Shingrix vaccine documented as administered or previously received

M1065

A

Shingrix vaccine was not administered for reasons documented by clinician (e.g.

M1066

A

Shingrix vaccine not documented as administered, reason not given

M1067

A

Hospice services for patient provided any time during the measurement period

M1068

A

Adults who are not ambulatory

M1069

A

Patient screened for future fall risk

M1070

A

Patient not screened for future fall risk, reason not given

M1071

A

Patient had any additional spine procedures performed on the same date as the

Q2042

A

Tisagenlecleucel, up to 600 million car-positive viable t cells, including

Q4183

A

Surgigraft, per square centimeter

Q4184

A

Cellesta, per square centimeter

Q4185

A

Cellesta flowable amnion (25 mg per cc); per 0.5 cc

Q4186

A

Epifix, per square centimeter

Q4187

A

Epicord, per square centimeter

Q4188

A

Amnioarmor, per square centimeter

Q4189

A

Artacent ac, 1 mg

Q4190

A

Artacent ac, per square centimeter

Q4191

A

Restorigin, per square centimeter

Q4192

A

Restorigin, 1 cc

Q4193

A

Coll-e-derm, per square centimeter

Q4194

A

Novachor, per square centimeter

Q4195

A

Puraply, per square centimeter

Q4196

A

Puraply am, per square centimeter

Q4197

A

Puraply xt, per square centimeter

Q4198

A

Genesis amniotic membrane, per square centimeter

Q4200

A

Skin te, per square centimeter

Q4201

A

Matrion, per square centimeter

Q4202

A

Keroxx (2.5g/cc), 1cc

Q4203

A

Derma-gide, per square centimeter

Q4204

A

Xwrap, per square centimeter

Q5103

A

Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg

Q5104

A

Injection, infliximab-abda, biosimilar, (renflexis), 10 mg

Q5105

A

Injection, epoetin alfa, biosimilar, (retacrit) (for esrd on dialysis), 100

Q5106

A

Injection, epoetin alfa, biosimilar, (retacrit) (for non-esrd use), 1000 units

Q5107

A

Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg

Q5108

A

Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg

Q5109

A

Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg

Q5110

A

Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram

Q9991

A

Injection, buprenorphine extended-release (sublocade), less than or equal to

Q9992

A

Injection, buprenorphine extended-release (sublocade), greater than 100 mg

T4545

A

Incontinence product, disposable, penile wrap, each

V5171

A

Hearing aid, contralateral routing device, monaural, in the ear (ite)

V5172

A

Hearing aid, contralateral routing device, monaural, in the canal (itc)

V5181

A

Hearing aid, contralateral routing device, monaural, behind the ear (bte)

V5211

A

Hearing aid, contralateral routing system, binaural, ite/ite

V5212

A

Hearing aid, contralateral routing system, binaural, ite/itc

V5213

A

Hearing aid, contralateral routing system, binaural, ite/bte

V5214

A

Hearing aid, contralateral routing system, binaural, itc/itc

V5215

A

Hearing aid, contralateral routing system, binaural, itc/bte

V5221

A

Hearing aid, contralateral routing system, binaural, bte/bte

0012M

A

Oncology (urothelial), mrna, gene expression profiling by real-time

0013M

A

Oncology (urothelial), mrna, gene expression profiling by real-time

0035U

A

Testing for presence of prion protein in cerebrospinal fluid

0036U

A

Exome gene analysis for somatic mutation in tumor tissue

0037U

A

DNA gene analysis of 324 genes in solid organ tumor tissue

0038U

A

Measurement of vitamin D in serum

0039U

A

Testing for anti-DNA antibody

0040U

A

Gene analysis (t(9;22)) for translocation analysis

0041U

A

IgM antibody detection test for Borrelia burgdorferi

0042U

A

IgG antibody detection test for Borrelia burgdorferi

0043U

A

IgM antibody detection test for Tick-Borne Relapsing Fever Borrelia group

0044U

A

IgM antibody detection test for Tick-Borne Relapsing Fever Borrelia group

0045U

A

mRNA gene analysis of 12 genes in breast ductal carcinoma in situ tumor tissue

0046U

A

Gene analysis (fms-related tyrosine kinase 3) for internal tandem duplication

0047U

A

mRNA gene analysis of 17 genes in prostate tumor tissue

0048U

A

DNA gene analysis of 468 genes in solid organ tumor tissue

0049U

A

Gene analysis (nucleophosmin)

0050U

A

DNA gene analysis of targeted sequences in 194 genes for acute myelogenous

0051U

A

Testing for presence of 31 prescription drugs in urine

0052U

A

Measurement of all five major lipoprotein classes and subclasses in blood

0053U

A

FISH analysis of 4 genes in prostate needle biopsy specimen

0054U

A

Measurement of 14 or more drug classes in capillary blood

0055U

A

DNA gene analysis of 96 target sequences in plasma for heart transplant

0056U

A

Whole genome sequencing in blood or bone marrow for acute myelogenous leukemia

0057U

A

mRNA gene analysis of 51 genes in solid organ tumor tissue

0058U

A

Measurement of antibodies to Merkel cell polyoma virus oncoprotein in serum

0059U

A

Test for presence of antibodies to Merkel cell polyoma virus oncoprotein in

0060U

A

Gene analysis for identical twins in maternal blood

0061U

A

Spatial frequency domain imaging of skin

0062U

A

Autoimmune (systemic lupus erythematosus), igg and igm analysis of 80

0063U

A

Neurology (autism), 32 amines by lc-ms/ms, using plasma, algorithm reported as

0064U

A

Antibody, treponema pallidum, total and rapid plasma reagin (rpr), immunoassay,

0065U

A

Syphilis test, non-treponemal antibody, immunoassay, qualitative (rpr)

0066U

A

Placental alpha-micro globulin-1 (pamg-1), immunoassay with direct optical

0067U

A

Oncology (breast), immunohistochemistry, protein expression profiling of 4

0068U

A

Candida species panel (c. albicans, c. glabrata, c. parapsilosis, c. kruseii, c

0069U

A

Oncology (colorectal), microrna, rt-pcr expression profiling of mir-31-3p,

0070U

A

Cyp2d6 (cytochrome p450, family 2, subfamily d, polypeptide 6) (eg, drug

0071U

A

Cyp2d6 (cytochrome p450, family 2, subfamily d, polypeptide 6) (eg, drug

0072U

A

Cyp2d6 (cytochrome p450, family 2, subfamily d, polypeptide 6) (eg, drug

0073U

A

Cyp2d6 (cytochrome p450, family 2, subfamily d, polypeptide 6) (eg, drug

0074U

A

Cyp2d6 (cytochrome p450, family 2, subfamily d, polypeptide 6) (eg, drug

0075U

A

Cyp2d6 (cytochrome p450, family 2, subfamily d, polypeptide 6) (eg, drug

0076U

A

Cyp2d6 (cytochrome p450, family 2, subfamily d, polypeptide 6) (eg, drug

0077U

A

Immunoglobulin paraprotein (m-protein), qualitative, immunoprecipitation and

0078U

A

Pain management (opioid-use disorder) genotyping panel, 16 common variants (ie,

0079U

A

Comparative dna analysis using multiple selected single-nucleotide

10004

A

Fine needle aspiration of additional lesion

10005

A

Fine needle aspiration of first lesion using ultrasound guidance

10006

A

Fine needle aspiration of additional lesion using ultrasound guidance

10007

A

Fine needle aspiration of first lesion using fluoroscopice guidance

10008

A

Fine needle aspiration of additional lesion using fluoroscopice guidance

10009

A

Fine needle aspiration of first lesion using CT guidance

10010

A

Fine needle aspiration of additional lesion using CT guidance

10011

A

Fine needle aspiration of first lesion using MR guidance

10012

A

Fine needle aspiration of additional lesion using MR guidance

11102

A

Tangential biopsy of single skin lesion

11103

A

Tangential biopsy of additional skin lesion

11104

A

Punch biopsy of single skin lesion

11105

A

Punch biopsy of additional skin lesion

11106

A

Incisional biopsy of single skin lesion

11107

A

Incisional biopsy of additional skin lesion

20932

A

Donor bone and joint graft to joint surface and neighboring bone

20933

A

Half-cylindrical donor bone graft

20934

A

Cylindrical donor bone graft

27369

A

Injection of contrast for imaging of knee joint

33274

A

Insertion or replacement of permanent leadless pacemaker into lower right

33275

A

Removal of permanent leadless pacemaker into lower right chamber of heart via

33285

A

Insertion of heart rhythm monitor under skin

33286

A

Removal of heart rhythm monitor from under skin

33289

A

Insertion of wireless pressure sensor into lung artery via catheter

33440

A

Replacement of aortic valve by translocation of pulmonary valve, replacement of

33866

A

Graft to half of aortic artery arch

36572

A

Insertion of central venous catheter for infusion using imaging guidance,

36573

A

Insertion of central venous catheter for infusion using imaging guidance,

38531

A

Open biopsy or excision of lymph nodes in groin

43762

A

Replacement of stomach stoma tube accessed through skin

43763

A

Replacement of stomach stoma tube accessed through skin with revision of stoma

50436

A

Enlargement of existing opening into urinary tract accessed through skin using

50437

A

Enlargement of existing opening into urinary tract accessed through skin and

53854

A

Destruction of prostate tissue accessed through urethra using radiofrequency

76391

A

Magnetic resonance (eg, vibration) elastography

76978

A

Ultrasound using targeted microbubble contrast of first lesion

76979

A

Ultrasound using targeted microbubble contrast of additional lesion

76981

A

Elastography ultrasound of organ tissue

76982

A

Elastography ultrasound of first lesion

76983

A

Elastography ultrasound of additional lesion

77046

A

MRI of one breast

77047

A

MRI of both breasts

77048

A

MRI of one breast with and without contrast

77049

A

MRI of both breasts with and without contrast

81163

A

Gene analysis (breast cancer 1 and 2) of full sequence

81164

A

Gene analysis (breast cancer 1 and 2) for duplication or deletion variants

81165

A

Gene analysis (breast cancer 1) of full sequence

81166

A

Gene analysis (breast cancer 1) for duplication or deletion variants

81167

A

Gene analysis (breast cancer 2) for duplication or deletion variants

81171

A

Gene analysis (fragile X mental retardation 2) for abnormal alleles

81172

A

Gene analysis (fragile X mental retardation 2) for characterization of alleles

81173

A

Gene analysis (androgen receptor) of full sequence

81174

A

Gene analysis (androgen receptor) for known familial variant

81177

A

Gene analysis (atropin 1) for abnormal alleles

81178

A

Gene analysis (ataxin 1) for abnormal alleles

81179

A

Gene analysis (ataxin 2) for abnormal alleles

81180

A

Gene analysis (ataxin 3) for abnormal alleles

81181

A

Gene analysis (ataxin 7) for abnormal alleles

81182

A

Gene analysis (ataxin 8 opposite strand non-protein codingÙ) for abnormal

81183

A

Gene analysis (ataxin 10) for abnormal alleles

81184

A

Gene analysis (calcium voltage-gated channel subunit alpha1 A) for abnormal

81185

A

Gene analysis (calcium voltage-gated channel subunit alpha1 A) of full sequence

81186

A

Gene analysis (calcium voltage-gated channel subunit alpha1 A) for known

81187

A

Gene analysis (CCH-type zinc finger nucleic acid binding protein) for abnormal

81188

A

Gene analysis (cystatin B) for abnormal alleles

81189

A

Gene analysis (cystatin B) of full sequence

81190

A

Gene analysis (cystatin B) for known familial variants

81204

A

Gene analysis (androgen receptor) for characterization of alleles

81233

A

Gene analysis (Bruton's tyrosine kinase) for common variants

81234

A

Gene analysis (DM1 protein kinase) for abnormal alleles

81236

A

Gene analysis (enhancer of zeste 2 polycomb repressive complex 2 subunit) of

81237

A

Gene analysis (enhancer of zeste 2 polycomb repressive complex 2 subunit) for

81239

A

Gene analysis (DM1 protein kinase) for characterization of alleles

81271

A

Gene analysis (Huntingtin) for abnormal alleles

81274

A

Gene analysis (Huntingtin) for characterization of alleles

81284

A

Gene analysis (frataxin) for abnormal alleles

81285

A

Gene analysis (frataxin) for characterization of alleles

81286

A

Gene analysis (frataxin) of full sequence

81289

A

Gene analysis (frataxin) for known familial variants

81305

A

Gene analysis (myeloid differentiation primary response 88) for p.Leu265Pro

81306

A

Gene analysis (nudix hydrolase 15) for common variants

81312

A

Gene analysis (polyAÙ binding protein nuclear 1) for abnormal alleles

81320

A

Gene analysis (phospholipase C gamma 2) for common variants

81329

A

Gene analysis (survival of motor neuron 1, telomeric) for dosage/deletion

81333

A

Gene analysis (transforming growth factor beta-induced) for common variants

81336

A

Gene analysis (survival of motor neuron 1, telomeric) of full sequence

81337

A

Gene analysis (survival of motor neuron 1, telomeric) for known familial

81343

A

Gene analysis (protein phosphatase 2 regulatory subunit Bbeta) for abnormal

81344

A

Gene analysis (TATA box binding protein) for abnormal alleles

81345

A

Gene analysis (telomerase reverse transcriptase) targeted sequence analysis

81443

A

Genomic sequence analysis panel for severe inherited conditions with sequencing

81518

A

mRNA gene analysis of 11 genes in breast tumor tissue

81596

A

Biochemical assays for evaluation of chronic Hepatitis C virus infection

82642

A

Measurement of dihydrotestosterone

83722

A

Measurement of small dense low density lipoprotein cholesterol

90689

A

Inactivated quadrivalent influenza vaccine for injection into muscle, 0.25 ml

92273

A

Full field recording of retinal electrical responses to external stimuli with

92274

A

Multifocal recording of retinal electrical responses to external stimuli with

93264

A

Remote monitoring of wireless pressure sensor in lung artery with qualified

95836

A

Recording of brain cortex electrical responses to implanted stimulation device

95976

A

Electronic analysis of implanted brain, spinal cord or peripheral stimulation

95977

A

Electronic analysis of implanted brain, spinal cord or peripheral stimulation

95983

A

Electronic analysis of implanted brain, spinal cord or peripheral stimulation

95984

A

Electronic analysis of implanted brain, spinal cord or peripheral stimulation

96112

A

Developmental test administration by qualified health care professional with

96113

A

Developmental test administration by qualified health care professional with

96121

A

Neurobehavioral status examination by qualified health care professional with

96130

A

Psychological testing evaluation by qualified health care professional, first

96131

A

Psychological testing evaluation by qualified health care professional,

96132

A

Neuropsychological testing evaluation by qualified health care professional,

96133

A

Neuropsychological testing evaluation by qualified health care professional,

96136

A

Psychological or neuropsychological test administration and scoring by

96137

A

Psychological or neuropsychological test administration and scoring by

96138

A

Psychological or neuropsychological test administration and scoring by

96139

A

Psychological or neuropsychological test administration and scoring by

96146

A

Psychological or neuropsychological test administration and scoring by single

97151

A

Behavior identification assessment by qualified health care professional, each

97152

A

Behavior identification assessment by technician under direction of qualified

97153

A

Adaptive behavior treatment by protocol, administered by technician under

97154

A

Adaptive behavior treatment by protocol, administered by technician under

97155

A

Adaptive behavior treatment with protocol modification administered by

97156

A

Family adaptive behavior treatment guidance by qualified health care

97157

A

Family adaptive behavior treatment guidance by qualified health care

97158

A

Group adaptive behavior treatment with protocol modification administered by

99451

A

Telephone or internet assessment and management service provided by

99452

A

Telephone or internet referral service, 30 minutes

99453

A

Remote monitoring of physiologic parameters, initial set-up and patient

99454

A

Remote monitoring of physiologic parameters, initial supply of devices with

99457

A

Remote monitoring of physiologic parameters management services, 20 minutes or

99491

A

Chronic care management services by qualified health care professional, 30

0505T

A

Reopening of arteries in thigh and behind knee with placement of stent via

0506T

A

Measurement of pigment density in retinas with interpretation and report

0507T

A

Near infrared dual imaging of tear glands with interpretation and report

0508T

A

Ultrasound measurement of bone density in shin bone

0509T

A

Pattern recording of retinal electrical responses to external stimuli with

0510T

A

Removal of implant from tunnel on outer side of foot (sinus tarsi)

0511T

A

Removal and reinsertion of implant from tunnel on outer side of foot (sinus

0512T

A

High energy shock wave therapy for initial wound of outer body surface

0513T

A

High energy shock wave therapy for additional wound of outer body surface

0514T

A

Visual axis identification using patient fixation during operation

0515T

A

Insertion of complete wireless heart stimulator system for pacing of lower left

0516T

A

Insertion of electrode of wireless heart stimulator system for pacing of lower

0517T

A

Insertion of pulse generator components of wireless heart stimulator system for

0518T

A

Removal of pulse generator components of wireless heart stimulator system for

0519T

A

Removal and replacement of pulse generator components of wireless heart

0520T

A

Removal and replacement of pulse generator components of wireless heart

0521T

A

Evaluation of parameters of wireless heart stimulator system for pacing of

0522T

A

Evaluation, testing, and programming adjustment of wireless heart stimulator

0523T

A

Measurement fractional flow reserve in arteries of heart with 3D functional

0524T

A

Chemical destruction of insufficient vein of arm or leg via catheter using

0525T

A

Insertion or replacement of complete monitoring system for deficient blood flow

0526T

A

Insertion or replacement of electrode of monitoring system for deficient blood

0527T

A

Insertion or replacement of implantable monitor of monitoring system for

0528T

A

Evaluation, testing, and programming adjustment of monitoring system for

0529T

A

Evaluation of parameters of monitoring system for deficient blood flow in heart

0530T

A

Removal of complete monitoring system for deficient blood flow in heart muscle

0531T

A

Removal of electrode of monitoring system for deficient blood flow in heart

0532T

A

Removal of implantable monitor of monitoring system for deficient blood flow in

0533T

A

Continuous recording of movement disorder symptoms for 8-10 days with set-up,

0534T

A

Continuous recording of movement disorder symptoms for 8-10 days with set-up,

0535T

A

Continuous recording of movement disorder symptoms for 8-10 days with data

0536T

A

Continuous recording of movement disorder symptoms for 8-10 days with download

0537T

A

Harvesting of blood-derived T white blood cells (T lymphocytes) for chimeric

0538T

A

Preparation of blood-derived T white blood cells (T lymphocytes) for

0539T

A

Receipt and preparation of blood-derived T white blood cells (T lymphocytes)

0540T

A

Administration of blood-derived T white blood cells (T lymphocytes) for

0541T

A

Imaging of heart muscle using magnetocardiography to detect deficient blood

0542T

A

Interpretation and report of imaging of heart muscle using magnetocardiography